4//SEC Filing
BIO REFERENCE LABORATORIES INC 4
Accession 0001019056-14-000911
CIK 0000792641operating
Filed
Jul 13, 8:00 PM ET
Accepted
Jul 14, 5:27 PM ET
Size
11.1 KB
Accession
0001019056-14-000911
Insider Transaction Report
Form 4
GRODMAN MARC
DirectorPresident, CEO10% Owner
Transactions
- Other
Common Stock
2014-07-11−244,550→ 159,464 total(indirect: By Trust) - Other
Common Stock
2014-07-11+244,550→ 1,937,502 total
Holdings
- 244,834(indirect: By Spouse)
Common Stock
- 200,000(indirect: By Trust)
Common Stock
- 200,000(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]On March 29, 2010, the reporting person transferred 1,000,000 directly-owned shares of Bio-Reference Laboratories, Inc. common stock to the Marc D. Grodman 2010 GRAT, a grantor retained annuity trust for the benefit of himself, his spouse and children (the "GRAT"). From May 2011 through May 2013, during which time the reporting person served as sole trustee of the GRAT and was therefore deemed the beneficial owner of all the shares in the GRAT, an aggregate total of 595,986 shares of common stock were transferred from the GRAT's to the reporting person's direct ownership in satisfaction of annual annuity payment obligations. (Continued in Footnote 2)
- [F2](Continued from Footnote 1) On March 29, 2014, the GRAT terminated on its terms and, effective as of March 28, 2014, Pam Gau Grodman, the reporting person's spouse, and Rich Faherty, were appointed as successor trustees (together the "Trustees") pursuant to the terms of the GRAT. On July 11, 2014, the Trustees directed that 244,550 shares remaining in the GRAT be transferred to the reporting person in satisfaction of the final annuity payment obligation of the GRAT to the reporting person. The remaining 159,464 shares of common stock originally placed into the GRAT are held by a successor trust and will be transferred to a trust for the benefit of the reporting person's family pursuant to the terms of the GRAT.
- [F3]The number of shares transferred from the GRAT to the reporting person were calculated based on the mean of the high and low reported market price of the common stock on July 3, 2014, the date on which the final transfer instructions were given. The average price on such date was $31.45.
- [F4]Includes 145,834 shares directly owned by the reporting person's wife and 99,000 shares owned by their children. The reporting person disclaims beneficial ownership of these 244,834 shares.
- [F5]Represents 200,000 shares held in trust for the benefit of the reporting person's wife and children, of which the reporting person and Mr. Ariel Fuentes are the co-trustees.
- [F6]Represents 200,000 shares held in trust for the benefit of the reporting person and children, of which the reporting person's wife is the trustee.
Documents
Issuer
BIO REFERENCE LABORATORIES INC
CIK 0000792641
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0000792641
Filing Metadata
- Form type
- 4
- Filed
- Jul 13, 8:00 PM ET
- Accepted
- Jul 14, 5:27 PM ET
- Size
- 11.1 KB